193 related articles for article (PubMed ID: 9689926)
1. Clear cell sarcoma or malignant melanoma of soft parts: molecular analysis of microsatellite instability with clinical correlation.
Aue G; Hedges LK; Schwartz HS; Bridge JA; Neff JR; Butler MG
Cancer Genet Cytogenet; 1998 Aug; 105(1):24-8. PubMed ID: 9689926
[TBL] [Abstract][Full Text] [Related]
2. Mismatch repair protein expression and microsatellite instability: a comparison of clear cell sarcoma of soft parts and metastatic melanoma.
Garcia JJ; Kramer MJ; O'Donnell RJ; Horvai AE
Mod Pathol; 2006 Jul; 19(7):950-7. PubMed ID: 16619000
[TBL] [Abstract][Full Text] [Related]
3. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
[TBL] [Abstract][Full Text] [Related]
4. Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene.
Moritake H; Sugimoto T; Asada Y; Yoshida MA; Maehara Y; Epstein AL; Kuroda H
Cancer Genet Cytogenet; 2002 May; 135(1):48-56. PubMed ID: 12072203
[TBL] [Abstract][Full Text] [Related]
5. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma.
Garcia JJ; Kramer MJ; Mackey ZB; O'Donnell RJ; Horvai AE
Arch Pathol Lab Med; 2006 Mar; 130(3):343-8. PubMed ID: 16519562
[TBL] [Abstract][Full Text] [Related]
6. Malignant melanoma of soft parts: a rare entity with a specific genetic marker.
Albert MV; Verdeguer A; Fernández JM; Castel V; Hernández M; Oltra JS
Pediatr Blood Cancer; 2006 May; 46(5):659. PubMed ID: 16261586
[No Abstract] [Full Text] [Related]
7. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases.
Hisaoka M; Ishida T; Kuo TT; Matsuyama A; Imamura T; Nishida K; Kuroda H; Inayama Y; Oshiro H; Kobayashi H; Nakajima T; Fukuda T; Ae K; Hashimoto H
Am J Surg Pathol; 2008 Mar; 32(3):452-60. PubMed ID: 18300804
[TBL] [Abstract][Full Text] [Related]
8. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling.
Segal NH; Pavlidis P; Noble WS; Antonescu CR; Viale A; Wesley UV; Busam K; Gallardo H; DeSantis D; Brennan MF; Cordon-Cardo C; Wolchok JD; Houghton AN
J Clin Oncol; 2003 May; 21(9):1775-81. PubMed ID: 12721254
[TBL] [Abstract][Full Text] [Related]
9. Clear cell tumors of the somatic soft tissues.
d'Amore ES; Ninfo V
Semin Diagn Pathol; 1997 Nov; 14(4):270-80. PubMed ID: 9383826
[TBL] [Abstract][Full Text] [Related]
10. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: clear cell sarcoma (malignant melanoma of soft parts).
Sandberg AA; Bridge JA
Cancer Genet Cytogenet; 2001 Oct; 130(1):1-7. PubMed ID: 11672766
[No Abstract] [Full Text] [Related]
11. Clear cell sarcoma of soft tissue: a retrospective review and analysis of 31 cases treated at Istituto Ortopedico Rizzoli.
Bianchi G; Charoenlap C; Cocchi S; Rani N; Campagnoni S; Righi A; Frisoni T; Donati DM
Eur J Surg Oncol; 2014 May; 40(5):505-510. PubMed ID: 24560887
[TBL] [Abstract][Full Text] [Related]
12. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
[TBL] [Abstract][Full Text] [Related]
13. Clear cell sarcoma of tendons and aponeuroses, and osteoclast-rich tumour of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: a review and update.
Kosemehmetoglu K; Folpe AL
J Clin Pathol; 2010 May; 63(5):416-23. PubMed ID: 20418233
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability in malignant melanoma.
Talwalkar VR; Scheiner M; Hedges LK; Butler MG; Schwartz HS
Cancer Genet Cytogenet; 1998 Jul; 104(2):111-4. PubMed ID: 9666803
[TBL] [Abstract][Full Text] [Related]
15. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients.
Kawai A; Hosono A; Nakayama R; Matsumine A; Matsumoto S; Ueda T; Tsuchiya H; Beppu Y; Morioka H; Yabe H;
Cancer; 2007 Jan; 109(1):109-16. PubMed ID: 17133413
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
19. Myxoid clear cell sarcoma.
Kim YC; Vandersteen DP; Jung HG
Am J Dermatopathol; 2005 Feb; 27(1):51-5. PubMed ID: 15677980
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts.
Hiraga H; Nojima T; Abe S; Yamashiro K; Yamawaki S; Kaneda K; Nagashima K
Virchows Arch; 1997 Jul; 431(1):45-51. PubMed ID: 9247632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
